Jackson Square Partners LLC decreased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,427 shares of the financial services provider’s stock after selling 2,969 shares during the quarter. Jackson Square Partners LLC’s holdings in CME Group were worth $8,227,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Lake Street Advisors Group LLC lifted its position in shares of CME Group by 108.7% during the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock worth $2,949,000 after purchasing an additional 6,453 shares during the last quarter. Meyer Handelman Co. acquired a new position in shares of CME Group during the 4th quarter worth about $6,144,000. Spire Wealth Management increased its holdings in shares of CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after acquiring an additional 359 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc raised its position in shares of CME Group by 19.3% during the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after acquiring an additional 52,862 shares in the last quarter. Finally, Unified Investment Management purchased a new stake in CME Group during the fourth quarter worth approximately $503,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Down 0.2 %
Shares of NASDAQ CME opened at $262.94 on Tuesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm’s 50-day moving average is $247.17 and its two-hundred day moving average is $234.65. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $267.91. The company has a market capitalization of $94.75 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53.
CME Group announced that its Board of Directors has initiated a share buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its shares are undervalued.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 1.90%. CME Group’s dividend payout ratio (DPR) is 51.71%.
Insider Activity
In other news, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company’s stock, valued at $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock valued at $6,871,496 over the last quarter. Company insiders own 0.30% of the company’s stock.
Analyst Ratings Changes
CME has been the topic of several recent analyst reports. Morgan Stanley increased their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Piper Sandler boosted their price target on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Keefe, Bruyette & Woods boosted their target price on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Finally, Oppenheimer boosted their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $238.93.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Quantum Gamble? Is IonQ’s Stock an Opportunity or a Mirage?
- How to Invest in Insurance Companies: A GuideĀ
- 4 Stocks Raising Dividends by More Than 10%
- 3 Warren Buffett Stocks to Buy Now
- Can SoundHound AI Double? What the Fundamentals and Deals Reveal
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.